Kangleweishi Biotechnology
A high-tech enterprise focusing on the development and production of innovative biomedicine in the public health field. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€420—630k (Dealroom.co estimates Sep 2008.)
China (HQ)
Authorizing premium user...